Daily Cannabis Use: A Novel Risk Factor of Steatosis Severity in Patients With Chronic Hepatitis C-Reference-Cited by-同舟云学术

Daily Cannabis Use: A Novel Risk Factor of Steatosis Severity in Patients With Chronic Hepatitis C

Published:2008-02 Issue:2 Volume:134 Page:432-439
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

Hézode Christophe,Zafrani Elie Serge,Roudot–Thoraval Françoise,Costentin Charlotte,Hessami Ali,Bouvier–Alias Magali,Medkour Fatiha,Pawlostky Jean–Michel,Lotersztajn Sophie,Mallat Ariane

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference42 articles.

1. Hepatitis C virus-induced hepatocellular steatosis;Castera;Am J Gastroenterol,2005

2. Steatosis in chronic hepatitis C: why does it really matter?;Asselah;Gut,2006

3. Impact of steatosis on progression of fibrosis in patients with mild hepatitis C;Fartoux;Hepatology,2005

4. Daily cannabis smoking as a risk factor for progression of fibrosis in chronic hepatitis C;Hezode;Hepatology,2005

5. Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis;Hourigan;Hepatology,1999

Cited by 163 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patterns and sociodemographic characteristics of substance abuse among hepatitis C virus-infected patients in Iraq: a cross-sectional study;The Egyptian Journal of Neurology, Psychiatry and Neurosurgery;2024-08-09

2. Expanding Research on Cannabis-Based Medicines for Liver Steatosis: A Low-Risk High-Reward Way Out of the Present Deadlock?;Cannabis and Cannabinoid Research;2023-02-01

3. Recreational cannabis use: French perspective of adverse effects;Cannabis Use, Neurobiology, Psychology, and Treatment;2023

4. Cannabinoids and Chronic Liver Diseases;International Journal of Molecular Sciences;2022-08-20

5. EASL Recognition Award Recipient 2022: Dr. Sophie Lotersztajn;Journal of Hepatology;2022-08